Oncode Institute
Harma Feitsma has a strong background in biotechnology and genomics, with experience in roles such as Business Developer, Senior Director Assay & Product Development, Head of Business Development in Oncology, and Senior Scientist in various companies including Oncode Institute, Cergentis, Philips, and Hubrecht Institute. With a focus on precision diagnostics, cancer research, and molecular diagnostics, Harma has demonstrated expertise in project management, team leadership, and developing partnerships in the clinical and research fields. Graduating from Wageningen University & Research with a Master's degree in Biotechnology, Harma's research background includes cancer genomics during their PhD research at Hubrecht Institute.
Oncode Institute
Oncode Institute is an independent institute dedicated to understanding cancer and translating research into practice. Oncode, starting from a deeper understanding of the basics of cancer, works to come up with better treatments and improved diagnostics. Our goal: helping more patients survive, improving the quality of life for those afflicted, and ultimately curing cancer. The complexity of cancer calls for strategic action and collaboration. Instead of new buildings, we are constructing a network, in which experienced, leading scientists and gifted young researchers at partner institutions strive together toward a greater, common goal, supported by KWF Kankerbestrijding and the Dutch Government. Because only by working together we can outsmart cancer. Official launch on February 5th, 2018 If you have any questions or suggestions, please feel free to contact us at anytime. info@oncode.nl